Please login to the form below
NICE
This page shows the latest NICE news and features for those working in and with pharma, biotech and healthcare.
NICE sets out plans for ‘ambitious’ five-year strategy
NICE refocuses on reducing health inequalities and accelerating access to the latest and most effective treatments. ... learning will bring digital health in disease prevention and self care to the fore,” said Sharmila Nebhrajani, NICE chair.
Latest news
-
Alexion and NICE agree confidential discount for Ultomiris use on the NHS
NICE said clinical evidence shows Ultomiris is as effective and safe as Alexion's older PNH drug Soliris. ... Compared with Alexion’s older drug, Ultomiris is a cost-effective use of NHS resources, concluded NICE.
-
NICE rejects Keytruda for advanced bladder cancer in final guidance
Following this rejection, MSD appealed the decision, although NICE has upheld its previous guidance not to recommend Keytruda as a second-line treatment for advanced bladder cancer patients. ... In a statement issued today, NICE said that although
-
Novartis and NHS England reach ‘landmark’ deal for Zolgensma gene therapy for SMA
Following the deal, the National Institute for Health and Care Excellence ( NICE) published a draft recommendation for the gene therapy. ... NICE has agreed a managed access agreement for Zolgensma, meaning that further data is set to be collected prior
-
NICE turns down bluebird bio’s gene therapy Zynteglo
NICE did add, however, that these trials suggest that eventually certain TDT patients treated with Zynteglo may no longer require blood transfusion or may require them less often. ... NICE’s draft guidance of Zynteglo is open for consultation until 4
-
Gilead’s Jyseleca is given a NICE recommendation for rheumatoid arthritis
Care Excellence (NICE). ... This is a landmark decision from NICE and represents a pivotal moment for the treatment of RA,” said James Galloway, consultant rheumatologist at King’s College London Hospital.
More from news
Approximately 398 fully matching, plus 830 partially matching documents found.
Latest Intelligence
-
Assessing the impact of disease prevalence on access and pricing of rare disease drugs in England
NICE uses CEA as the primary method for jointly assessing the clinical and economic impact of new drugs. ... This helps explain the non-linearity of the relationship between disease prevalence and AATC for ODs assessed by NICE.
-
Setting up for success in a post-Brexit, post-pandemic Britain
Recently, Galapagos and Gilead Sciences received a positive NICE recommendation for Jyseleca (filgotinib) for use on the NHS which, for the first time, will support access to an advanced therapy for ... With three COVID-19 vaccines approved for use in
-
The remote working revolution
It is a nice leveller because we are all just people trying to do the best we can in difficult circumstances.”.
-
Mapping at launch: it’s time to update the satnav
Example – GSK’s Trelegy: a moment-in-time snapshot. Trelegy launched in the UK for COPD at the end of 2017, with an Evidence Summary from NICE published in June 2018.
-
Can digital communications boost behaviour change?
Digital health interventions. New NICE guidelines, published in October 2020, highlight goal planning, monitoring and social support as the components to focus on when developing digital health interventions.
More from intelligence
Approximately 12 fully matching, plus 126 partially matching documents found.
Latest appointments
-
NICE looks internally for new chief executive
He was appointed in April 1999 when NICE was first established under Tony Blair’s ‘New Labour’ government. ... I am delighted that Gill has been appointed as NICE’s next chief executive.
-
Professor Carole Longson moves from NICE to the ABPI
The Association of the British Pharmaceutical Industry (ABPI) has attracted Professor Carole Longson away from the National Institute for Health and Care Excellence (NICE) to be its new chief scientific officer, ... She most recently spent the 18 years
-
New health ministers and re-appointments after reshuffle
Freeman's role is also tied into the Department for Business, Innovation and Skills and includes expanded responsibility for the Cancer Drugs Fund, NICE and MHRA, research and development, issues around
-
Virgo Health Education appoints new senior team
She has over 15 years' experience working in medical education and is a member of the ISMPP Ethics Committee, the NICE Implementation External Reference Group and part of the Royal Berkshire
-
Former NICE chair Sir Michael Rawlins to lead MHRA
Care Excellence (NICE) from its formation in 1999 to his departure last year.
More from appointments
Approximately 4 fully matching, plus 10 partially matching documents found.
Latest from PMHub
-
Abbie's (associate copywriter) first 6-months at COUCH Health
Yet, it’s so nice that I’ve not felt disconnected from the company at all, considering most of my interaction with the team has been online.
-
Why it’s in everyone’s interest the Women’s Health Strategy for England succeeds
5. This strategy isn’t just a nice to have, a way for the Government to appeal to women voters.
-
WHITE PAPER: What's missing in women's health?
NHS. https://www.nhs.uk/conditions/menopause/. treatment/. Accessed December 23, 2019. 5. Menopause. NICE CKS. ... https://cks.nice.org.uk/menopause#! backgroundSub. Accessed January 6, 2020. 6. Harman C, Bower E.
-
Living with psoriasis: a patient perspective
ii] NICE Psoriasis Quality Standards Indicator. National Institute of Health and Care Excellence 2012.
-
Good design saves lives
Good design and creativity are vital to this process. This campaign by Fresenius Kabi is a nice illustration of these ideas in practice.
More from PMHub
Approximately 2 fully matching, plus 58 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Head of Strategic Planning, Healthcare Advertising/ Brand comms,...
-
Six figure salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Account Management
-
Competitive Salary Offered
- Senior & Principal Medical Writer
-
Competitive Salary Offered
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
-
Medical Editor
-
Competitive Salary
-
Senior Medical Writer
-
Competitive Salary
-
Account Manager
-
Competitive Salary
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
-
Publications Director
-
Competitive Salary
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Senior Account Manager/ Account Director
-
Competitive Salary Offered
-
Associate Account Director
-
Competitive Salary
- Account Manager - Creative Healthcare Communications - South Wes...
-
Excellent Remuneration
- Group Account Director, Healthcare Advertising/ Brand comms, Lon...
-
8 month contract up to £90K
-
Senior Account Executive
-
Competitive Salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
- Merck & Co reveals plans for women’s health spinoff Organon
- bluebird bio aiming to separate business units by year-end
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Single dose of COVID-19 vaccines ‘significantly’ reduces infections
- Lilly signs $1.25bn collaboration deal with MiNA Therapeutics
- Origins Insights wins the “Best Patient-Centric Approach” award at the BHBIA BOBI Awards 2021
- Emergency authorisation for Pfizer/BioNTech vaccine expanded in the US
- Biogen and Capsigen to collaborate on gene therapies
- AZ, Amgen file first-in-class asthma drug with the FDA
- Sharing patient stories for World Pulmonary Hypertension Day
- Top 10 Tips to Increase Engagement During Virtual Events
- Pfizer’s COVID-19 vaccine yields $3.5bn in first quarter sales
- Sourcing R&D innovation: why pharma companies need to evolve their business models
- 5 ways that lockdowns and restrictions could be affecting our allergies
- BioNTech on course to produce three billion doses of Pfizer-partnered COVID-19 vaccine in 2021
- Eli Lilly/AbCellera’s COVID-19 variant-targeting antibody enters clinical trials
PMHub
Havas Life Medicom
We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...
Latest intelligence
- Sharing patient stories for World Pulmonary Hypertension Day
- For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...
- How nature can help you manage the pressures of agency life
- Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
- How can we strike the right balance between familiarity and innovation when it comes to data presentation?
- Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
